Delivery Order SPE2DX22D0030-SPE2D826F0AA1
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,710.88 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 2, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $75,110.56 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 1, 2025, with completion scheduled for September 2, 2025. This firm fixed-price delivery order, issued without set-aside restrictions, represents a competitive award under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,413.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with ultimate completion by August 5, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger indefinite delivery vehicle, this award reflects AmerisourceBergen's role...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $791,968.14 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $53,486.47 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 1, 2025, with completion scheduled for September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $181,081.98 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under which AmerisourceBergen will supply pharmaceutical products and medical supplies to support federal military and healthcare operations. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,788.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,413.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation and will be performed at the vendor's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $870,087.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $296,361.86 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DX22D0030Indefinite Delivery Contract
- SPE2DX22D0030-SPE2D826F0AA1Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $536,063.79 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support federal military and veteran healthcare systems. The company's contract portfolio with DLA encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order is part of DLA's pharmaceutical procurement strategy, which includes plans for establishing Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $536.1k | 10/1/25 |